×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BHC – bausch health companies inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BHC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
08:22 am
bhc
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis [Yahoo! Finance]
Low
Report
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis [Yahoo! Finance]
11/18
08:22 am
bhc
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS [Yahoo! Finance]
Low
Report
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS [Yahoo! Finance]
11/18
08:00 am
bhc
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
Low
Report
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
11/18
08:00 am
bhc
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Low
Report
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
11/14
02:08 pm
bhc
Photodynamic Therapy Market to Grow by USD 2.35 Billion (2024-2028), Driven by Rising Cancer Prevalence, AI-Powered Report Highlights Market Trends - Technavio [Yahoo! Finance]
Low
Report
Photodynamic Therapy Market to Grow by USD 2.35 Billion (2024-2028), Driven by Rising Cancer Prevalence, AI-Powered Report Highlights Market Trends - Technavio [Yahoo! Finance]
11/6
11:24 am
bhc
Are Medical Stocks Lagging Bausch Health (BHC) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Bausch Health (BHC) This Year? [Yahoo! Finance]
11/6
06:42 am
bhc
Indonesia Medical Aesthetics Market Report 2024-2029 - 11.5% CAGR Forecast, with Market Set to Reach USD 495.64 Million by 2029 [Yahoo! Finance]
Medium
Report
Indonesia Medical Aesthetics Market Report 2024-2029 - 11.5% CAGR Forecast, with Market Set to Reach USD 495.64 Million by 2029 [Yahoo! Finance]
11/5
01:13 pm
bhc
At 11.1% CAGR Aesthetic Medical Devices Market Size to Reach $44.60 Billion By 2031 | The Insight Partners [Yahoo! Finance]
Low
Report
At 11.1% CAGR Aesthetic Medical Devices Market Size to Reach $44.60 Billion By 2031 | The Insight Partners [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
10/30/2024
04:05 pm
BHC
bausch health companies inc.
MISS
Report
12.6%
bausch health companies inc.
8/1/2024
07:00 am
BHC
bausch health companies inc.
MISS
Report
2.7%
bausch health companies inc.
5/2/2024
07:00 am
BHC
bausch health companies inc.
MISS
Report
-12.9%
bausch health companies inc.
2/22/2024
07:00 am
BHC
bausch health companies inc.
MISS
Report
6.5%
bausch health companies inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/1
04:32 pm
bhc
Form 8-K Bausch Health Companies For: Nov 01
Medium
Report
Form 8-K Bausch Health Companies For: Nov 01
10/31
06:06 am
bhc
Form 10-Q Bausch Health Companies For: Sep 30
Medium
Report
Form 10-Q Bausch Health Companies For: Sep 30
10/30
04:17 pm
bhc
Form 8-K Bausch Health Companies For: Oct 30
Medium
Report
Form 8-K Bausch Health Companies For: Oct 30
10/1
04:17 pm
bhc
Form 4 Bausch Health Companies For: Sep 30 Filed by: WECHSLER AMY B
Low
Report
Form 4 Bausch Health Companies For: Sep 30 Filed by: WECHSLER AMY B
10/1
04:16 pm
bhc
Form 4 Bausch Health Companies For: Sep 30 Filed by: ICAHN BRETT
Low
Report
Form 4 Bausch Health Companies For: Sep 30 Filed by: ICAHN BRETT
10/1
04:16 pm
bhc
Form 4 Bausch Health Companies For: Sep 30 Filed by: Paulson John
Low
Report
Form 4 Bausch Health Companies For: Sep 30 Filed by: Paulson John
9/9
04:54 pm
bhc
Form 4 Bausch Health Companies For: Sep 05 Filed by: Carson Seana
Low
Report
Form 4 Bausch Health Companies For: Sep 05 Filed by: Carson Seana
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Bausch Health To Reduce Debt By Approximately $100 Million Using Cash Generated From Operations
16.8%
4/9 Form SC 13G Bausch Health Companies Filed by: GLENVIEW CAPITAL MANAGEMENT, LLC 10.6%
5/3 Form 4 Bausch Health Companies For: May 01 Filed by: ValueAct Holdings II, L.P. 8.9%
12/12 Bausch Health Companies Inc (NYSE: BHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $38.00 price target on the stock, up previously from $32.00. 6.3%
8/20 Form 4 Bausch Health Companies For: Aug 16 Filed by: Humphries William D. 4.5%
3/30 VRX Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) Investors 4.3%
8/7 Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form 4.1%
4/29 Bausch Health Companies Inc (NYSE: BHC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock. 3.8%
3/24 Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic 3.7%
2/19 Bausch Health reports $1.52-billion fourth-quarter loss due to stock drop lawsuit settlement [Toronto Globe and Mail (Ontario, Canada)] 3.7%
4/9 Form SC 13G Bausch Health Companies Filed by: GLENVIEW CAPITAL MANAGEMENT, LLC 10.6%
5/3 Form 4 Bausch Health Companies For: May 01 Filed by: ValueAct Holdings II, L.P. 8.9%
12/12 Bausch Health Companies Inc (NYSE: BHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $38.00 price target on the stock, up previously from $32.00. 6.3%
8/20 Form 4 Bausch Health Companies For: Aug 16 Filed by: Humphries William D. 4.5%
3/30 VRX Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) Investors 4.3%
8/7 Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form 4.1%
4/29 Bausch Health Companies Inc (NYSE: BHC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock. 3.8%
3/24 Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic 3.7%
2/19 Bausch Health reports $1.52-billion fourth-quarter loss due to stock drop lawsuit settlement [Toronto Globe and Mail (Ontario, Canada)] 3.7%
TOP News Decliners
3/14
Insider Buying: Richard DeSchutter Just Spent US$185k On Bausch Health Companies Inc. (NYSE:BHC) Shares [Yahoo! Finance News]
-19.1%
3/11 Form 4 Bausch Health Companies For: Mar 10 Filed by: VON ESCHENBACH ANDREW C. -13.3%
10/1 BRIEF-Bausch Health Files Lawsuit Against Sandoz Inc [Reuters] -10.6%
3/17 Bausch Health CEO’s 2019 pay climbs to US$17.14-million [Toronto Globe and Mail (Ontario, Canada)] -8.6%
4/1 Bausch Health Companies: The Sell-Off Looks Overdone [The Motley Fool] -8.3%
2/26 Value Investor Bill Miller Talks About Amazon And Bitcoin At Forbes/SHOOK Top Advisor Summit [Forbes] -7.9%
8/6 Q2/2019 6/30/2019 EPS -0.490 ZacksConsensus 1.060 ActVsEst (1.550) - Miss -7.8%
8/13 Form 4 Bausch Health Companies For: Aug 09 Filed by: ACKERMANN CHRISTINA -7.1%
2/19 Q4/2019 12/31/2019 EPS 4.300 ZacksConsensus 1.150 ActVsEst 3.150 - Beat -6.2%
4/28 Bausch Health Companies Inc (NYSE: BHC) had its price target lowered by analysts at Royal Bank of Canada from $26.00 to $25.00. They now have a "sector perform" rating on the stock. -5.8%
3/11 Form 4 Bausch Health Companies For: Mar 10 Filed by: VON ESCHENBACH ANDREW C. -13.3%
10/1 BRIEF-Bausch Health Files Lawsuit Against Sandoz Inc [Reuters] -10.6%
3/17 Bausch Health CEO’s 2019 pay climbs to US$17.14-million [Toronto Globe and Mail (Ontario, Canada)] -8.6%
4/1 Bausch Health Companies: The Sell-Off Looks Overdone [The Motley Fool] -8.3%
2/26 Value Investor Bill Miller Talks About Amazon And Bitcoin At Forbes/SHOOK Top Advisor Summit [Forbes] -7.9%
8/6 Q2/2019 6/30/2019 EPS -0.490 ZacksConsensus 1.060 ActVsEst (1.550) - Miss -7.8%
8/13 Form 4 Bausch Health Companies For: Aug 09 Filed by: ACKERMANN CHRISTINA -7.1%
2/19 Q4/2019 12/31/2019 EPS 4.300 ZacksConsensus 1.150 ActVsEst 3.150 - Beat -6.2%
4/28 Bausch Health Companies Inc (NYSE: BHC) had its price target lowered by analysts at Royal Bank of Canada from $26.00 to $25.00. They now have a "sector perform" rating on the stock. -5.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: